<DOC>
	<DOCNO>NCT00513396</DOCNO>
	<brief_summary>The need standardize treatment protocol multidrug resistant tuberculosis ( MDR-TB ) resource-limited country increasingly recognize . This single center , double blind , randomize control trial design compare time require sputum culture conversion extent radiological improvement case MDR pulmonary tuberculosis isoniazid include ( regular dose high dose ) adjuvant standardize second line treatment . The study design test hypothesis inclusion high-dose isoniazid enhance effectiveness second line treatment case MDR-TB without significantly increase toxicity .</brief_summary>
	<brief_title>High-Dose Isoniazid Adjuvant Therapy Multidrug Resistant Tuberculosis</brief_title>
	<detailed_description>Tuberculosis declare global emergency World Health Organization ( WHO ) 1993 . The global problem tuberculosis complicate substantial increase drug resistant tuberculosis . Available data suggest drug resistant TB especially multi drug resistant may represent public health threat area high prevalence tuberculosis , suboptimal TB control program and/ HIV . The cure rate case report low non-drug resistant TB failure rate 44 % . New therapy MDR-TB introduce since fluoroquinolones 1970s . Strains Mycobacterium Tuberculosis ( M . tub . ) H resistant case often contain mixture susceptible &amp; resistant organism . Use high dose H ( 16- 20 mg/kg ) eliminate susceptible &amp; low level resistance4 . This Study do evaluate role isoniazid ( INH ) high &amp; normal dosage adjuvant therapy treatment patient persistent culture positive pulmonary tuberculosis despite 6 month continuous first line antitubercular treatment culture least resistant isoniazid rifampicin .</detailed_description>
	<mesh_term>Tuberculosis</mesh_term>
	<mesh_term>Tuberculosis , Multidrug-Resistant</mesh_term>
	<mesh_term>Isoniazid</mesh_term>
	<criteria>Consecutive patient report study center Sputumpositive acidfast bacillus HIVuninfected MDRTB define resistance least follow two drug : Isoniazid Rifampicin . Unwilling give consent Abnormal renal hepatic profile History suggestive isoniazid hypersensitivity Pregnancy Lactating mother Previous history take follow : kanamycin , prothionamide , levofloxacin , cycloserine paminosalicylic acid</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2007</verification_date>
	<keyword>Randomized control trial</keyword>
	<keyword>multidrug resistant tuberculosis</keyword>
	<keyword>isoniazid</keyword>
	<keyword>standardize regimen</keyword>
	<keyword>adjuvant therapy</keyword>
</DOC>